Literature DB >> 22095712

The tumor suppressor ARF regulates innate immune responses in mice.

Paqui G Través1, Raquel López-Fontal, Alfonso Luque, Sonsoles Hortelano.   

Abstract

The innate immune system is the first line of defense against invading organisms, and TLRs are the main sensors of microbial components, initiating signaling pathways that induce the production of proinflammatory cytokines and type I IFNs. An antiviral action for the tumor suppressor alternative reading frame (ARF) has been reported; however, the precise role of ARF in innate immunity is unknown. In this study, we show that ARF plays an important role in regulation of inflammatory responses. In peritoneal macrophages and bone marrow-derived macrophages from ARF-deficient animals, the induction of proinflammatory cytokines and chemokines by TLR ligands was severely impaired. The altered responses of ARF(-/-) cells to TLR ligands result from aberrant activation of intracellular signaling molecules including MAPKs, IκBα degradation, and NF-κB activation. Additionally, animals lacking ARF were resistant to LPS-induced endotoxic shock. This impaired activation of inflammation in ARF(-/-) mice was not restricted to TLRs, as it was also shown in response to non-TLR signaling pathways. Thus, ARF(-/-) mice were also unable to trigger a proper inflammatory response in experimental peritonitis or in 12-O-tetradecanoylphorbol-13-acetate-induced edema. Overexpression of ARF, but not its downstream target p53, rescued the ARF-deficient phenotype, increasing TLR4 levels and restoring inflammatory reaction. An increase in the E2F1 protein levels observed in ARF(-/-) macrophages at basal condition and after LPS stimulation may be involved in the impaired response in this system, as E2F1 has been described as an inflammatory suppressor. These results indicate that tumor suppressor ARF is a new regulator of inflammatory cell signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095712     DOI: 10.4049/jimmunol.1004070

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Cellular senescence in renal ageing and disease.

Authors:  Ines Sturmlechner; Matej Durik; Cynthia J Sieben; Darren J Baker; Jan M van Deursen
Journal:  Nat Rev Nephrol       Date:  2016-12-28       Impact factor: 28.314

2.  Globule Leukocytes and Other Mast Cells in the Mouse Intestine.

Authors:  Peter Vogel; Laura Janke; David M Gravano; Meifen Lu; Deepali V Sawant; Dorothy Bush; E Shuyu; Dario A A Vignali; Asha Pillai; Jerold E Rehg
Journal:  Vet Pathol       Date:  2017-05-11       Impact factor: 2.221

Review 3.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

4.  Tumor suppressor ARF: The new player of innate immunity.

Authors:  Paqui G Través; Alfonso Luque; Sonsoles Hortelano
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

5.  Role of the tumor suppressor ARF in macrophage polarization: Enhancement of the M2 phenotype in ARF-deficient mice.

Authors:  Sandra Herranz; Paqui G Través; Alfonso Luque; Sonsoles Hortelano
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

6.  The ARF tumor suppressor targets PPM1G/PP2Cγ to counteract NF-κB transcription tuning cell survival and the inflammatory response.

Authors:  Usman Hyder; Jennifer L McCann; Jinli Wang; Victor Fung; Juan Bayo; Iván D'Orso
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-07       Impact factor: 12.779

7.  p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia.

Authors:  Alper Yetil; Benedict Anchang; Arvin M Gouw; Stacey J Adam; Tahera Zabuawala; Ramya Parameswaran; Jan van Riggelen; Sylvia Plevritis; Dean W Felsher
Journal:  Oncotarget       Date:  2015-02-28

Review 8.  Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game.

Authors:  Paqui G Través; Alfonso Luque; Sonsoles Hortelano
Journal:  Mediators Inflamm       Date:  2012-12-18       Impact factor: 4.711

9.  Functional polymorphisms in interleukin-23 receptor and susceptibility to esophageal squamous cell carcinoma in Chinese population.

Authors:  Bin Ni; Shaomu Chen; Hongya Xie; Haitao Ma
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  ARF: connecting senescence and innate immunity for clearance.

Authors:  Alper Y Kearney; Benedict Anchang; Sylvia Plevritis; Dean W Felsher
Journal:  Aging (Albany NY)       Date:  2015-09       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.